A detailed history of Martingale Asset Management L P transactions in Nuvalent, Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 6,104 shares of NUVL stock, worth $514,078. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,104
Previous 6,104 -0.0%
Holding current value
$514,078
Previous $463,000 34.77%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$62.76 - $81.61 $172,590 - $224,427
2,750 Added 81.99%
6,104 $463,000
Q1 2024

May 14, 2024

BUY
$72.35 - $88.99 $242,661 - $298,472
3,354 New
3,354 $251,000

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.62B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.